Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31503128 | 0.91 | TSHR (0.61) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL6373627 | 0.88 | TSHR (0.56) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL13431383 | 0.85 | TSHR (0.58) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL30775458 | 0.84 | TSHR (0.52) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL9913181 | 0.84 | TSHR (0.52) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL30985266 | 0.83 | TSHR (0.56) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL19770540 | 0.83 | TSHR (0.56) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL5972801 | 0.83 | TSHR (0.56) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL11128153 | 0.83 | TSHR (0.56) | TSHRLMNAALDH1A1RECQLEPHX2 | |
| SCHEMBL3502791 | 0.82 | TSHR (0.82) | TSHRLMNAALDH1A1RECQLEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326204-A1 | FLOW CELL SYSTEMS AND METHODS | NAUTILUS SUBSIDIARY INC (US) | 2025-10-23 | — | — | US | disclosed |
| US-12377635-B2 | Flow cell systems and methods | NAUTILUS SUBSIDIARY, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-12306093-B2 | Methods and systems for integrated on-chip single-molecule detection | NAUTILUS SUBSIDIARY, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| US-20250075101-A1 | SURFACE TREATMENT | Interphase Materials, Inc (US) | 2025-03-06 | — | — | US | disclosed |
| US-12146071-B2 | Surface treatment | INTERPHASE MATERIALS INC. (US) | 2024-11-19 | — | — | US | disclosed |
| US-20230256425-A1 | INORGANIC POROUS SUBSTRATE, INORGANIC POROUS SUPPORT, AND NUCLEIC ACID PRODUCTION METHOD | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230221243-A1 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | NAUTILUS SUBSIDIARY, INC. | 2023-07-13 | — | — | US | disclosed |
| US-20230213438-A1 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | NAUTILUS SUBSIDIARY, INC. | 2023-07-06 | — | — | US | disclosed |
| CN-115461143-A | Compositions, methods, and systems for sample processing | 10X基因组学有限公司 | 2022-12-09 | — | — | CN | disclosed |
| US-20220379582-A1 | FLOW CELL SYSTEMS AND METHODS | NAUTILUS SUBSIDIARY, INC. | 2022-12-01 | — | — | US | disclosed |
| US-20130177770-A1 | BONDING METHOD, BONDABILITY IMPROVING AGENT, SURFACE MODIFICATION METHOD, SURFACE MODIFYING AGENT, AND NOVEL COMPOUND | SULFUR CHEMICAL INSTITUTE INCORPORATED (JP) | 2013-07-11 | — | — | US | disclosed |
| EP-2503330-A2 | Multicapillary device for sample preparation | Chromba, Inc. (US) | 2012-09-26 | — | — | EP | disclosed |
| EP-2319956-B1 | Metallizing a zone of porous silicon by in situ reduction and application in a fuel cell | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2012-03-21 | — | — | EP | disclosed |
| US-20110263838-A1 | MULTICAPILLARY DEVICE FOR SAMPLE PREPARATION | BELOV YURI P | 2011-10-27 | — | — | US | disclosed |
| US-20110130616-A1 | Magnetically Responsive Nanoparticle Therapeutic Constructs and Methods of Making and Using | SWR&D INC. | 2011-06-02 | — | — | US | disclosed |
| EP-2319956-A1 | Metallizing a zone of porous silicon by in situ reduction and application in a fuel cell | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2011-05-11 | — | — | EP | disclosed |
| US-20110086165-A1 | METALLIZATION OF A POROUS SILICON ZONE BY IN SITU REDUCTION AND APPLICATION TO A FUEL CELL | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2011-04-14 | — | — | US | disclosed |
| WO-2011042620-A1 | FORMATION OF METAL PARTICLES ON A SOLID OXIDE SUBSTRATE HAVING TWO SEPARATE GRAFTED CHEMICAL FUNCTIONS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2011-04-14 | — | — | WO | disclosed |
| US-20100055416-A1 | COMPOSITE AND MANUFACTURING METHOD THEREOF | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20070017870-A1 | Multicapillary device for sample preparation | BIOEDGE, LLC | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230256425-A1 | INORGANIC POROUS SUBSTRATE, INORGANIC POROUS SUPPORT, AND NUCLEIC ACID PRODUCTION METHOD | DNMT3L, FBL, SIK1 | TSHR 4846/4885LMNA 373/4885ALDH1A1 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.